WELCOME TO
BSG LIVE’25

Connect • Learn Innovate
Industry Symposia – Madrigal Pharmaceuticals

MASH in clinical practice: What is the impact and how to identify at-risk patients?

Thursday 26 June 12:50-13:20

The objective of this non-promotional symposium is to educate the audience on metabolic dysfunction-associated steatohepatitis (MASH) and to increase the awareness of the audience on: 

  • The burden of the disease 
  • How to identify patient with MASH consistent with F2-F3 based on local guidelines 

Speakers:

Dr Daniel Forton, St George’s University Hospitals NHS Foundation Trust.

Dr Lynsey Corless, Hull University Teaching Hospitals NHS Trust.

3 minutes –  Welcome and Introductions – Dr Forton
10 minute – The Growing Burden of MASH: Epidemiology, Pathophysiology, and Global Impact – Dr Corless
10 minutes –  Diagnosis and Risk Stratification of Liver Fibrosis in MASH – Dr Forton
7 minutes – Discussion

BACK